“Moving EGFR Targeted Therapy into the Induction Phase of the Management of Squamous Cell Carcinoma of the Head and Neck ”, J. Can. Res. Updates, vol. 1, no. 1, pp.  14–21, Jan. 2012, doi: 10.6000/1929-2279.2012.01.01.04.